Complete mesocolic excision for right hemicolectomy: an updated systematic review and meta-analysis
Techniques in Coloproctology · 6 authors, 4 centres
AI SUMMARY
FIDELITY 100%
POPULATIONAdult patients with primary non-metastatic right colon cancer undergoing right hemicolectomy
INTERVENTIONComplete mesocolic excision (CME)
COMPARISONStandard right hemicolectomy (non-CME)
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
A systematic review and meta-analysis of 24 comparative studies evaluated complete mesocolic excision versus standard right hemicolectomy for primary right colon cancer. CME was associated with greater lymph node harvest, improved 5-year overall and disease-free survival, and reduced local recurrence, without increasing perioperative morbidity.
Full summary
981 CHARS
This systematic review followed PRISMA 2020 guidelines and searched Web of Science, PubMed/Medline, and Embase through February 22, 2023. Among 24 included comparative studies, meta-analysis using random-effects models found that CME significantly increased lymph node harvest (MD 9.62; 95% CI 5.83–13.41; p > 0.0001), 5-year overall survival (OR 1.88; 95% CI 1.14–3.09; p = 0.01), and 5-year disease-free survival (OR 2.21; 95% CI 1.51–3.23; p < 0.0001), and decreased local recurrence (OR 0.27; 95% CI 0.09–0.79; p = 0.02). Perioperative morbidity was similar between groups (OR 1.04; 95% CI 0.89–1.22; p = 0.97). Main limitations include the predominance of observational cohort studies with inherent selection bias risk, heterogeneous pathological specimen quality assessment, potential publication bias, and variable reporting of adjuvant therapy use. The authors conclude that results need confirmation from high-quality randomised controlled trials with long-term follow-up.
PICO
PPOPULATION
Adult patients with primary non-metastatic right colon cancer undergoing right hemicolectomy
IINTERVENTION
Complete mesocolic excision (CME)
OOUTCOME
Short-term postoperative morbidity and mortality; long-term oncological outcomes including lymph node harvest, 5-year overall survival, 5-year disease-free survival, and local recurrence